Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2007

01.10.2007 | Epidemiology

Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients

verfasst von: Mogens Groenvold, Morten Aagaard Petersen, Ellen Idler, Jakob Bue Bjorner, Peter M. Fayers, Henning T. Mouridsen

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

This study examined whether psychological distress in newly diagnosed breast cancer patients was associated with their survival. We analyzed data from 1,588 breast cancer patients who filled in the EORTC QLQ-C30 questionnaire and the Hospital Anxiety and Depression Scale (HADS) 2 months after their primary operation. The median follow-up time was 12.9 years. Psychological distress (EORTC QLQ-C30 emotional function; HADS anxiety; HADS depression) and EORTC fatigue, physical function, and overall ratings were used to predict recurrence-free and overall survival, controlling for the known clinical and histopathological prognostic factors (biological model) using Cox multivariate regression analysis. Low levels of psychological distress (good EORTC emotional function) and low fatigue independently predicted longer recurrence-free and overall survival, controlling for biological factors. Lack of anxiety (HADS) also predicted longer recurrence-free survival. When added in combination to the biological model, fatigue remained a significant predictor of recurrence-free survival (P = 0.0004; risk ratio 1.32 (1.13–1.54)) and emotional function remained a significant predictor of overall survival (P = 0.0074; risk ratio 0.81 (0.70–0.95)). Low psychological distress and a low level of fatigue may cause a greater cancer resistance or may reflect underlying mental and physical robustness.
Literatur
1.
Zurück zum Zitat Spiegel D, Bloom JR, Kraemer HC, Gottheil E (1989) Effects of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888–891PubMedCrossRef Spiegel D, Bloom JR, Kraemer HC, Gottheil E (1989) Effects of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888–891PubMedCrossRef
2.
Zurück zum Zitat Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL (1993) Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681–689PubMed Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL (1993) Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681–689PubMed
3.
Zurück zum Zitat Cunningham AJ, Edmonds CV, Jenkins GP, Pollack H, Lockwood GA, Warr D (1998) A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 7:508–517PubMedCrossRef Cunningham AJ, Edmonds CV, Jenkins GP, Pollack H, Lockwood GA, Warr D (1998) A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 7:508–517PubMedCrossRef
4.
Zurück zum Zitat Edelman S, Lemon J, Bell DR, Kidman AD (1999) Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology 8:474–481PubMedCrossRef Edelman S, Lemon J, Bell DR, Kidman AD (1999) Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology 8:474–481PubMedCrossRef
5.
Zurück zum Zitat Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, Drysdale E, Hundleby M, Chochinov HM, Navarro M, Speca M, Hunter J (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726PubMedCrossRef Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, Drysdale E, Hundleby M, Chochinov HM, Navarro M, Speca M, Hunter J (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726PubMedCrossRef
6.
Zurück zum Zitat Kissane DW, Love A, Hatton A, Bloch S, Smith G, Clarke DM, Miach P, Ikin J, Ranieri N, Snyder RD (2004) Effect of cognitive-existential group therapy on survival in early-stage breast cancer. J Clin Oncol 22:4255–4260PubMedCrossRef Kissane DW, Love A, Hatton A, Bloch S, Smith G, Clarke DM, Miach P, Ikin J, Ranieri N, Snyder RD (2004) Effect of cognitive-existential group therapy on survival in early-stage breast cancer. J Clin Oncol 22:4255–4260PubMedCrossRef
7.
Zurück zum Zitat Coates A, Thomson D, McLeod GR, Hersey P, Gill PG, Olver IN, Kefford R, Lowenthal RM, Beadle G, Walpole E (1993) Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 29A:1731–1734PubMedCrossRef Coates A, Thomson D, McLeod GR, Hersey P, Gill PG, Olver IN, Kefford R, Lowenthal RM, Beadle G, Walpole E (1993) Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 29A:1731–1734PubMedCrossRef
8.
Zurück zum Zitat Kaasa S, Mastekaasa A, Lund E (1989) Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients’ subjective experience of disease and psychosocial well-being. Radiother Oncol 15:235–242PubMedCrossRef Kaasa S, Mastekaasa A, Lund E (1989) Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients’ subjective experience of disease and psychosocial well-being. Radiother Oncol 15:235–242PubMedCrossRef
9.
Zurück zum Zitat Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67:3131–3135PubMedCrossRef Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67:3131–3135PubMedCrossRef
10.
Zurück zum Zitat Efficace F, Bottomley A, Coens C, van Steen K, Conroy T, Schoffski P, Schmoll H, Van Cutsem E, Kohne CH (2006) Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 42:42–49PubMedCrossRef Efficace F, Bottomley A, Coens C, van Steen K, Conroy T, Schoffski P, Schmoll H, Van Cutsem E, Kohne CH (2006) Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 42:42–49PubMedCrossRef
11.
Zurück zum Zitat Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D (2004) Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 13:1209–1216PubMedCrossRef Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D (2004) Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 13:1209–1216PubMedCrossRef
12.
Zurück zum Zitat Roychowdhury DF, Hayden A, Liepa AM (2003) Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 21:673–678PubMedCrossRef Roychowdhury DF, Hayden A, Liepa AM (2003) Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 21:673–678PubMedCrossRef
13.
Zurück zum Zitat McCarter H, Furlong W, Whitton AC, Feeny D, DePauw S, Willan AR, Barr RD (2006) Health status measurements at diagnosis as predictors of survival among adults with brain tumors. J Clin Oncol 24:3636–3643PubMedCrossRef McCarter H, Furlong W, Whitton AC, Feeny D, DePauw S, Willan AR, Barr RD (2006) Health status measurements at diagnosis as predictors of survival among adults with brain tumors. J Clin Oncol 24:3636–3643PubMedCrossRef
14.
Zurück zum Zitat Sullivan PW, Nelson JB, Mulani PM, Sleep D (2006) Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Qual Life Res 15:1297–1306PubMedCrossRef Sullivan PW, Nelson JB, Mulani PM, Sleep D (2006) Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Qual Life Res 15:1297–1306PubMedCrossRef
15.
Zurück zum Zitat Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IF (1999) Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. J Clin Epidemiol 52:653–666PubMedCrossRef Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IF (1999) Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. J Clin Epidemiol 52:653–666PubMedCrossRef
16.
Zurück zum Zitat Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 38:1351–1357PubMedCrossRef Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 38:1351–1357PubMedCrossRef
17.
Zurück zum Zitat Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M, Forbes JF (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 10:1833–1838PubMed Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M, Forbes JF (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 10:1833–1838PubMed
18.
Zurück zum Zitat Coates AS, Hurny C, Peterson HF, Bernhard J, Castiglione-Gertsch M, Gelber RD, Goldhirsch A (2000) Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 18:3768–3774PubMed Coates AS, Hurny C, Peterson HF, Bernhard J, Castiglione-Gertsch M, Gelber RD, Goldhirsch A (2000) Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 18:3768–3774PubMed
19.
Zurück zum Zitat Efficace F, Biganzoli L, Piccart M, Coens C, van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A (2004) Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40:1021–1030PubMedCrossRef Efficace F, Biganzoli L, Piccart M, Coens C, van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A (2004) Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40:1021–1030PubMedCrossRef
20.
Zurück zum Zitat Kramer JA, Curran D, Piccart M, de Haes JC, Bruning P, Klijn J, Van Hoorebeeck I, Paridaens R (2000) Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 36:1498–1506PubMedCrossRef Kramer JA, Curran D, Piccart M, de Haes JC, Bruning P, Klijn J, Van Hoorebeeck I, Paridaens R (2000) Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 36:1498–1506PubMedCrossRef
21.
Zurück zum Zitat Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmstrom P, Valvere V, Tennvall L, Blomqvist C (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 39:1370–1376PubMedCrossRef Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmstrom P, Valvere V, Tennvall L, Blomqvist C (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 39:1370–1376PubMedCrossRef
22.
Zurück zum Zitat Tross S, Herndon II J, Korzun A, Kornblith AB, Cella DF, Holland JF, Raich P, Johnson A, Kiang DT, Perloff M, Norton L, Wood W, Holland JC (1996) Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst 88:661–667PubMedCrossRef Tross S, Herndon II J, Korzun A, Kornblith AB, Cella DF, Holland JF, Raich P, Johnson A, Kiang DT, Perloff M, Norton L, Wood W, Holland JC (1996) Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst 88:661–667PubMedCrossRef
23.
Zurück zum Zitat Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, Bottomley A (2004) Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 22:3381–3388PubMedCrossRef Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, Bottomley A (2004) Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 22:3381–3388PubMedCrossRef
24.
Zurück zum Zitat Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P (2006) Baseline psychosocial predictors of survival in localised breast cancer. Br J Cancer 94:1245–1252PubMedCrossRef Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P (2006) Baseline psychosocial predictors of survival in localised breast cancer. Br J Cancer 94:1245–1252PubMedCrossRef
25.
Zurück zum Zitat Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KI, Trudeau ME, Koo J, Hood N (2004) Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 22:4184–4192PubMedCrossRef Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KI, Trudeau ME, Koo J, Hood N (2004) Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 22:4184–4192PubMedCrossRef
26.
Zurück zum Zitat Watson M, Haviland JS, Greer S, Davidson J, Bliss JM (1999) Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354:1331–1336PubMedCrossRef Watson M, Haviland JS, Greer S, Davidson J, Bliss JM (1999) Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354:1331–1336PubMedCrossRef
27.
Zurück zum Zitat Watson M, Homewood J, Haviland J, Bliss JM (2005) Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer 41:1710–1714PubMedCrossRef Watson M, Homewood J, Haviland J, Bliss JM (2005) Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer 41:1710–1714PubMedCrossRef
28.
Zurück zum Zitat Wulsin LR, Vaillant GE, Wells VE (1999) A systematic review of the mortality of depression. Psychosom Med 61:6–17PubMed Wulsin LR, Vaillant GE, Wells VE (1999) A systematic review of the mortality of depression. Psychosom Med 61:6–17PubMed
29.
Zurück zum Zitat Idler EL, Benyamini Y (1997) Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38:21–37PubMedCrossRef Idler EL, Benyamini Y (1997) Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38:21–37PubMedCrossRef
30.
Zurück zum Zitat Bjorner JB, Kristensen TS, Orth-Gomér K, Tibblin G, Sullivan M, Westerholm P (1996) Self-rated health: a useful concept in research, prevention and clinical medicine. Swedish Council for Planning and Coordination of Research, Stockholm Bjorner JB, Kristensen TS, Orth-Gomér K, Tibblin G, Sullivan M, Westerholm P (1996) Self-rated health: a useful concept in research, prevention and clinical medicine. Swedish Council for Planning and Coordination of Research, Stockholm
31.
Zurück zum Zitat Rumsfeld JS, MaWhinney S, McCarthy M Jr, Shroyer AL, VillaNueva CB, O’Brien M, Moritz TE, Henderson WG, Grover FL, Sethi GK, Hammermeister KE (1999) Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA 281:1298–1303PubMedCrossRef Rumsfeld JS, MaWhinney S, McCarthy M Jr, Shroyer AL, VillaNueva CB, O’Brien M, Moritz TE, Henderson WG, Grover FL, Sethi GK, Hammermeister KE (1999) Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA 281:1298–1303PubMedCrossRef
32.
Zurück zum Zitat Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG (1999) Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 61:26–37PubMed Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG (1999) Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 61:26–37PubMed
33.
Zurück zum Zitat Petticrew M, Bell R, Hunter D (2002) Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 325:1066PubMedCrossRef Petticrew M, Bell R, Hunter D (2002) Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 325:1066PubMedCrossRef
34.
Zurück zum Zitat Danish Breast Cancer Cooperative Group (1989) DBCG-89. Program for treatment and follow-up of patients with primary, operable breast cancer [In Danish]. DBCG-Sekretariatet, Copenhagen Danish Breast Cancer Cooperative Group (1989) DBCG-89. Program for treatment and follow-up of patients with primary, operable breast cancer [In Danish]. DBCG-Sekretariatet, Copenhagen
35.
Zurück zum Zitat Groenvold M (1997) Quality of life in breast cancer adjuvant therapy: validation and pilot testing of a combination of questionnaires. Breast 6:97–107CrossRef Groenvold M (1997) Quality of life in breast cancer adjuvant therapy: validation and pilot testing of a combination of questionnaires. Breast 6:97–107CrossRef
36.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishmann SB, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishmann SB, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
37.
Zurück zum Zitat Fayers PM, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A and on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organization for Research and Treatment of Cancer, Brussels Fayers PM, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A and on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organization for Research and Treatment of Cancer, Brussels
38.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef
39.
Zurück zum Zitat Hansen EJ (1986) Social classes in Denmark [In Danish]. Danish National Institute of Social Research, Copenhagen Hansen EJ (1986) Social classes in Denmark [In Danish]. Danish National Institute of Social Research, Copenhagen
40.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942CrossRef Early Breast Cancer Trialists’ Collaborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942CrossRef
41.
Zurück zum Zitat Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale–a review of validation data and clinical results. J Psychosom Res 42:17–41PubMedCrossRef Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale–a review of validation data and clinical results. J Psychosom Res 42:17–41PubMedCrossRef
42.
Zurück zum Zitat Schmoor C, Schumacher M (1997) Effects of covariate omission and categorization when analysing randomized trials with the Cox model. Stat Med 16:225–237PubMedCrossRef Schmoor C, Schumacher M (1997) Effects of covariate omission and categorization when analysing randomized trials with the Cox model. Stat Med 16:225–237PubMedCrossRef
43.
Zurück zum Zitat Garssen B, Goodkin K (1999) On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res 85:51–61PubMedCrossRef Garssen B, Goodkin K (1999) On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res 85:51–61PubMedCrossRef
44.
Zurück zum Zitat Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486PubMedCrossRef Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486PubMedCrossRef
Metadaten
Titel
Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients
verfasst von
Mogens Groenvold
Morten Aagaard Petersen
Ellen Idler
Jakob Bue Bjorner
Peter M. Fayers
Henning T. Mouridsen
Publikationsdatum
01.10.2007
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2007
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9447-x

Weitere Artikel der Ausgabe 2/2007

Breast Cancer Research and Treatment 2/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.